| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.1M | -57.8% |
| Cost of Revenue | $5.0M | -56.6% |
| R&D Expense | $39.0M | +14.3% |
| SG&A Expense | $31.5M | -50.5% |
| Operating Income | -$121.0M | +31.7% |
| Pre-tax Income | -$115.6M | +28.2% |
| Income Tax | $7K | +100.2% |
| Net Income | -$115.6M | +26.4% |
| EPS (Basic) | -$4.51 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.1M | -34.2% |
| Short-term Investments | $15.9M | -79.9% |
| Accounts Receivable | $555K | -70.3% |
| Inventory | $1.1M | -70.1% |
| Current Assets | $45.1M | -65.1% |
| Total Assets | $60.4M | -64.0% |
| Current Liabilities | $8.5M | -19.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.6M | -17.2% |
| Capital Expenditures | $782K | -47.8% |
| Investing Cash Flow | $64.7M | +159.3% |
| Financing Cash Flow | -$82K | +98.9% |
| Free Cash Flow | -$77.4M | -15.7% |
| -321.5% |
| EPS (Diluted) | -$4.51 | -321.5% |
| Total Liabilities |
| $19.5M |
| -15.8% |
| Stockholders' Equity | $40.9M | -71.7% |